Stocktoria

MYRIAD GENETICS INC MYGN

Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-06 · LEI

MYRIAD GENETICS INC institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.15,150,806$370.6M16.2%
MILLENNIUM MANAGEMENT LLC6,668,817$30.0M7.13%
D. E. Shaw & Co., Inc.4,499,724$20.2M4.81%
AQR CAPITAL MANAGEMENT LLC1,912,296$8.6M2.05%
TWO SIGMA INVESTMENTS, LP1,284,050$5.8M1.37%
Point72 Asset Management, L.P.957,901$4.3M1.02%
CITADEL ADVISORS LLC490,842$2.2M0.52%
RENAISSANCE TECHNOLOGIES LLC454,374$2.0M0.49%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.